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Introduction
Squamous cell carcinoma (SCC) of the oral cavity
by virtue of its location has a profound impact on a patient's
nutritional intake by impairing either functional chewing,
swallowing or leading to a decreased mouth opening
(trismus). The primary management of these tumours by
surgery, chemotherapy or radiotherapy further stresses the
patient's nutritional status and may impair his nutritional
intake. Surgical modalities have been associated with severe
trismus due to oedema and extensive reconstruction in
oropharyngeal cancers. Concurrent chemo/radio therapy
advocated for organ preservation in advanced head and neck
cancers has also been associated with severe mucositis and
dysphagia. Studies report an incidence of 87%, 30 days after
treatment.1 Chronic dysphagia has also been reported in 12-
69% of nasopharyngeal cancer patients 6-9 months after
their treatment.2
The nutritional needs of a cancer patient have
already been well documented. Studies show that nearly 40-
50% of head and neck cancer patients have a markedly
impaired nutritional status at the time of their initial
presentation.3-5 Fifty five percent have a negative energy
balance throughout the course of the disease6 Severe weight
loss has been documented in 58% of patients without enteral
nutritional support.7 The patients' nutritional status has a
significant impact on his quality of life, morbidity and
mortality.6,8 Studies show that patients who had better
nutritional status had fewer complications9 and showed
improved survival trends when compared with
malnourished patients.10 A prospective cohort showed that
in the 38% of patients with impaired nutrition the 2-year
survival was only 7.5% when compared to over 57% in the
remainder of the cohort.10 In fact, Mick et al claimed that
the strongest independent predictor of survival in
multimodality treated stage III/IV head and neck cancer was
pretreatment weight loss.11
Morbidities associated with poor nutrition during the
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Abstract
Objectives: Squamous cell carcinoma of the oral cavity has a profound impact on a patient's nutritional intake, 40-
50% of head and neck cancer patients have a markedly impaired nutritional status at the time of their initial
presentation. Studies show that patients who have better nutritional status have fewer complications and a better
survival rate. Therefore, enteral nutritional support plays an important part in their management. Due to the lack of
relevant data, surgeons help patients make informed decisions regarding their mode of nutritional support and
perform gastrostomy or place nasogastric tube depending on the patient's preference. This study addresses the need
for scientific data regarding the impact and psychosocial acceptance of both these modalities in our population.
Methods: A retrospective review of patient's charts with a principle diagnosis of squamous cell carcinoma of
the oral cavity, receiving surgery +/- adjuvant radiotherapy was carried out. Patients were also questioned
regarding their experience with the mode of nutrition and its impact on their life during their regular follow up
consultations. Post therapy change in weight, psychosocial acceptance and quality of life were considered as
measures of outcome.
Results: A mean weight loss of 5.43 ± 3.4 kg (p=0.025) was noticed in 15 patients on nasogastric feeding. On
the other hand, significantly less weight loss of 1.25 ± 5.12 kg (p=0.025)was noticed in the patients receiving
nutrition via gastrostomy tubes; nine patients had a mean weight gain of 2.89 ± 1.95 kg and the rest had similar
weight loss of 5.427 ± 3.4 kg.
Conclusion: The authors of the study recommend that gastrostomies should be considered for patients
requiring long term post operative enteral nutritional support in patients of head and neck cancers.
Keywords: Enteral nutritional support, Nasogastric feeding, Gastrostomy, Squamous cell carcinoma, Oral
cavity. (JPMA 61:1042; 2011).
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course of disease include surgical site infections, wound
dehiscence and impaired healing, along with an inability to
tolerate anti-neoplastic drugs and immunosuppression.
Keeping this in mind, nutritional augmentation was
provided to all the cases presenting to our department.
Traditionally, nasogastric (NG) feeding was being used to
augment the patients' nutritional status; however recently
surgeons advocate the use of gastrostomy (G) tubes for this
purpose. Due to a lack of relevant guidelines, data on
psychosocial acceptance and the limited financial
capabilities of patients, our surgeons help patients make
informed decisions regarding their mode of nutritional
support and perform Gastrostomy or place an NG tube
depending on the patient's preference. Our study addresses
the need for relevant data regarding the impact and
psychosocial acceptance of both modalities in our
population.
Patients and Methods
A retrospective review of patient's progress charts
was carried out. Records of all patients with a principle
diagnosis of oral cavity squamous cell carcinoma,
receiving surgery ± adjuvant radiotherapy between the
years 2006-2008 and receiving enteral nutritional support
were reviewed and their details were recorded in a preset
questionnaire. Patients were also questioned regarding
their experience with the mode of nutrition and its impact
on their life during their regular follow up consultations.
Post therapy change in weight, psychosocial acceptance
and quality of life were considered as measures of
outcome.
A total of 32 patient's records were reviewed with
16 receiving nutritional support via NG tubes (Group 1)
and 16 via G tubes (Group 2). SPSS v.16 was used for
storage and analysis of data. Descriptive frequencies were
calculated for age, gender and radiotherapy doses for
comparing both groups, while t-test and chi square test
were applied to calculate the significance of change in
weight and patient acceptance between two groups
respectively.
Results
Our sample consisted of 27 male and 5 female
patients; out of which 14 males and 2 females opted for
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Table-1: Summary of participants and outcomes of both feeding modalities.
Group 1 (NG) Group 2 (Gastrostomy)
Number Percentage Number Percentage
Disease Stage
Stage I 0 0 0 0
Stage II 5 31.25 3 18.75
Stage III 1 6.25 2 12.5
Stage IV 10 62.5 11 68.75
Surgery
Flap Reconstruction 7 43.75 7 43.75
Neck Dissection 16 100 16 100
Mandibulectomy 5 31.25 8 50
Radiation
>6000 cGy 3 18.75 1 6.25
=6000 cGy 5 31.25 8 50
Data NA 8 50 7 43.75
Complications of Radiation
Mucositosis 16 100 16 100
Dysphagia 16 100 16 100
Loss of taste 16 100 13 81.25
Xerostomia 14 87.5 10 62.5
Odynophagia 16 100 8 50
Complications of feeding
Tube Dislodgement 2 12.5 0 0
Stomal Leak 0 0 1 6.25
Wound Infection 0 0 2 12.5
Gastroesophageal Reflux 9 56.25 0 0
Aspiration Pneumonia 2 12.5 0 0
Patient Acceptance and Rating
Excellent 1 6.25 2 12.5
Good 0 0 5 31.25
Fair 5 31.25 5 31.25
Poor 10 62.5 4 25
Recommendation for other patients 0 0 16 100
gastrostomy over NG feeding. Both groups receiving
NG or G tube feeding were comparable in all other
aspects with mean ages 49 ± 7.94 and 47 ± 10.99 years
respectively and a similarly distributed staging of the
disease. The extent of surgery and radiation therapy was
also similar as 7 flap reconstructions, 16 neck
dissections and 5 mandibulectomies were performed in
group 1 compared to 7 flap reconstructions, 16 neck
dissections and 8 mandibulectomies in group 2,
augmented by >6000 cGy of radiation in 3 patients and
=6000 cGy in 5 patients of group 1 compared to >6000
cGy of radiation in 1 patient and =6000 cGy in 8 patients
of group 2 (Table).
No significant differences were present in the side
effects of radiotherapy. However, fewer patients had
associated loss of taste, xerostomia and odynophagia in
group 2 as compared to group 1. The incidence of
mucositis and dysphagia was similar between both groups
(Table).
Out of 16 patients in group 1, a mean weight loss
of 5.43 ± 3.4 kg from the point of diagnosis to their last
follow up consultation was noticed in 15 patients and 1
was noticed to gain 1.5 kg weight. In group 2 the mean
weight loss was significantly lower at 1.25 ± 5.12 kg
(p=0.025), nine patients had a mean weight gain of 2.89 ±
1.95 kg and the rest had similar weight loss of 5.427 ± 3.4
kg . However, it is of interest to note that patients in group
1 were able to receive enteral nutritional support for a
mean period of 15 days compared to 6 months in group 2.
Fewer complications were noted in group 2 as only
1 patient developed a stromal leak and 2 patients had
surgical site infections, when compared to group 1 where
2 patients had dislodged NG tubes, 2 contracted aspiration
pneumonia and 9 developed clinically significant
Gastroesophageal reflux disease (GERD) (Table).
Patient acceptance was also better in group 2 with
a 100% recommending G tubes for other patients and 7
patients describing their experience as good or excellent
compared to 1 patient in group 1 and no recommendations
for NG tubes (Table).
Discussion
The nutritional needs of head and neck cancer
patients have been well documented. Major indicators of
long-term postoperative nutritional support include stage
IV cancers, primary pharyngeal tumours, tumors treated
with concomitant surgery and radiotherapy, and
preoperative weight loss of more than 10 pounds (4.535
kg).12 Studies have shown that patients undergoing
radiotherapy for head and neck cancer have eating
disabilities and the disability increases with duration and
dosage of therapy.13,14 The findings of our study concur
with this pattern. 
A recent study showed that early enteral nutrition
improves treatment tolerance and outcomes in head and
neck cancer patients undergoing concurrent chemo
radiotherapy, resulting in fewer complications and
hospital admissions.15 The study found that patients
receiving NG tube feeding lost comparatively less weight
during chemo radiotherapy than controls and had fewer
treatment breaks indicating the importance of nutritional
support in head and neck cancer.16 However NG tube
feeding is a temporary means of enteral supplementation
requiring constant replacement. It is poorly tolerated due
to the constant need for replacement, aesthetic outlook
along with the associated issues of gastro-oesophageal
reflux, aspiration, nasal ulceration and frequent blockage
of the tube. Prolonged use has also been associated with
pressure necrosis of the nasal ala as well as the mucosa of
the upper aerodigestive tract. 
Gastrostomy tubes are now found to be preferable
due to their greater mobility, better cosmetic appearance
and improved subjective quality of life.17,18 They also
sustain higher flow rates as compared to NG tubes
accommodating bolus feeds. Due to these advantages
over traditionally used NG tubes, it has become the
modality of choice for patients requiring long term enteral
nutritional support. 
Our patients responded well to gastrostomy tubes
with 100% recommending them to other patients
requiring nutritional support. Also, the duration of enteral
feeding with gastrostomy tubes was significantly higher
than those receiving NG feeding. Patients could tolerate
an NG tube for a mean duration of 15 days as compared
to 6 months on gastrostomy. Thus the patients requiring
long term nutritional support should be considered for
feeding gastrostomies. The longer duration of enteral
nutritional support as demonstrated in our study will have
a greater impact on the patient's nutritional status,
improved quality of life and overall survival rate.
Variable complication rates have been reported for
gastrostomies throughout literature ranging from 6% to
17.5% for minor complications and 2.7% to 22.5% for
major complications.19 Minor complications include
peristomal wound infection, tube obstruction and leakage
whereas major complications include peritonitis,
premature removal and intestinal perforation.20 Studies
have shown that gastrostomy tube usage may be
associated with long-term swallowing disability in a small
percentage of patients, especially in older individuals.21,22
However pretreatment swallowing exercises may further
decrease its incidence, as it has been shown to produce
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measurable improvement in post treatment swallowing
function in patients undergoing organ-preservation chemo
radiotherapy for head and neck cancers.23
When comparing the two modalities, we would
recommend the use of gastrostomy tubes for long term
post operative enteral nutritional support over NG tubes
due to increased patient compliance and acceptance as
well as longer duration of feeding and better functional
outcomes.
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